Kevin C. Tang, Director, 10% Owner at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 20,000 shares at $19.85 ($397K) on 2016-03-04, disclosed to the SEC on 2016-03-08.
Open-market purchase of $397k LJPC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |